NCT07533825 2026-04-16
CGCA202501
Tianjin Medical University Cancer Institute and Hospital
Phase NA Enrolling by invitation
Clinical Trials
87 trialsNCT06133439 2026-04-14
RISCC
Indiana University
Phase NA Enrolling by invitation
NCT07517419 2026-04-08
PIPAC in Gastric Peritoneal Metastasis
Chinese University of Hong Kong
Phase 2 Enrolling by invitation
NCT06506955 2026-04-03
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT07503847 2026-03-31
Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49
National Taiwan University Hospital
Phase NA Enrolling by invitation
NCT07218003 2026-03-23
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT07488312 2026-03-23
LUCENT-GC-01
Qilu Hospital of Shandong University
Phase 1 Enrolling by invitation
NCT06191185 2026-03-11
IMPACTT
University of California, San Francisco
Phase NA Enrolling by invitation
NCT07441369 2026-03-02
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Fudan University
Phase 2 Enrolling by invitation
NCT07444099 2026-03-02
Early Postoperative Intervention in Gastric Cancer Patients
Qilu Hospital of Shandong University
Phase NA Enrolling by invitation
NCT05441475 2026-02-25
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
Abbisko Therapeutics Co, Ltd
Phase 2 Enrolling by invitation
NCT07429760 2026-02-24
Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Phase NA Enrolling by invitation
NCT06458998 2026-02-23
GTI
University of Pittsburgh
Phase NA Enrolling by invitation
NCT07116668 2026-02-18
SAFE-3CV
SafeHeal Inc
Phase NA Enrolling by invitation
NCT06184594 2026-02-17
Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Icahn School of Medicine at Mount Sinai
Phase NA Enrolling by invitation
NCT06822530 2026-02-17
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Fred Hutchinson Cancer Center
Phase NA Enrolling by invitation
NCT06061328 2026-02-04
OASIS
VA Office of Research and Development
Phase NA Enrolling by invitation
NCT07386704 2026-02-04
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Peking University First Hospital
Phase 2 Enrolling by invitation
NCT07380867 2026-02-02
Tattooing
Seoul St. Mary's Hospital
Phase NA Enrolling by invitation
NCT07381985 2026-02-02
LINC
University of Vermont Medical Center
Phase NA Enrolling by invitation
NCT07376980 2026-01-29
MST
Korea University Anam Hospital
Phase NA Enrolling by invitation
NCT02081755 2026-01-27
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Baylor Research Institute
Phase 4 Enrolling by invitation
NCT07371247 2026-01-27
Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT05443321 2026-01-23
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Phase NA Enrolling by invitation
NCT07356466 2026-01-21
FUGES032
Fujian Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07346534 2026-01-16
Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study
Shanghai 10th People's Hospital
Phase NA Enrolling by invitation
NCT07347158 2026-01-16
Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.
Hospital Clinico Universitario de Santiago
Phase NA Enrolling by invitation
NCT06603519 2026-01-15
Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
University of California, San Diego
Phase NA Enrolling by invitation
NCT07344220 2026-01-15
DZ-002-201
Hoag Memorial Hospital Presbyterian
Phase 2 Enrolling by invitation
NCT07334587 2026-01-12
Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma
Allama Iqbal Medical College
Phase NA Enrolling by invitation
NCT07106359 2026-01-07
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham
Phase NA Enrolling by invitation
NCT07139951 2025-12-31
HORIZON
Mayo Clinic
Phase 2 Enrolling by invitation
NCT07312578 2025-12-31
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
Peking University
Phase 2 Enrolling by invitation
NCT06462521 2025-12-30
CARDINAL
Indiana University
Phase NA Enrolling by invitation
NCT07310069 2025-12-30
TRANSFORM-GBC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Enrolling by invitation
NCT07050485 2025-12-29
Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
University of South Florida
Phase NA Enrolling by invitation
NCT06744595 2025-12-12
Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer
Mayo Clinic
Phase NA Enrolling by invitation
NCT06269744 2025-12-02
PROOF
NYU Langone Health
Phase NA Enrolling by invitation
NCT06603987 2025-11-19
Using CICS-1 and SPM-011 and ï¼»18Fï¼½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Stella Pharma Corporation
Phase 1/2 Enrolling by invitation
NCT07230795 2025-11-17
AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT04561791 2025-10-22
Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
Massachusetts General Hospital
Phase NA Enrolling by invitation
NCT06401174 2025-10-22
SCREEN
Medstar Health Research Institute
Phase NA Enrolling by invitation
NCT06636864 2025-09-25
Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Colorectal Cancer Surgery
Sun Yat-sen University
Phase NA Enrolling by invitation
NCT06882876 2025-09-19
JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
Xiangya Hospital of Central South University
Phase 1 Enrolling by invitation
NCT06085560 2025-09-16
Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
Michigan State University
Phase NA Enrolling by invitation
NCT04246970 2025-09-15
PreLiveR-T
Hospital Universitario La Fe
Phase NA Enrolling by invitation
NCT06931860 2025-09-09
Head to Head Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
Phase NA Enrolling by invitation
NCT06228209 2025-09-04
TIER-PC
Icahn School of Medicine at Mount Sinai
Phase NA Enrolling by invitation
NCT06936527 2025-09-03
XS-03-II201
NovaOnco Therapeutics Co., Ltd.
Phase 1/2 Enrolling by invitation
NCT05385861 2025-08-15
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
National Health Research Institutes, Taiwan
Phase 1/2 Enrolling by invitation